skip to content

Cambridge Cardiovascular


A discovery innovations leader and mentor across target selection, pipeline delivery to first time in human (FiH) and the related technology stack. 22 years experience (Cambridge Antibody Technology, MedImmune & AstraZeneca) as a biologics and antibody engineer, team leader, pipeline project leader and mentor of leaders. A very experienced and successful multidisciplinary team leader with an exemplary high performance track record. Contributing to and leading teams delivering 18 FiH IND Biologics (IgG, peptides, ADC, bispecifics) of which 3, to date, made BLA and are marketed medicines. Highlights include IMFINZI, PB2452, MEDI6570, AZD3427 & AZD9592.


Key publications: 
Principal Scientist: Discovery Innovation for FiH drugs

Contact Details


Person keywords: 
aiml, collaboration, targeted therapy, antibodytherapeutics